New study highlights increasing incidence of late-onset multiple sclerosis in Italy
The shift to older incident cases may suggest changes in the epidemiology of the disease.
Comment & Opinion
DREAM-HF trial sheds positive light on Revascor for ischemic HF
Highest risk CLL patients may benefit from CAR T with BTK inhibitor
Knock-on effects of alcohol consumption during the Covid-19 pandemic in Brazil
ASH 2024: inMIND study results position Monjuvi as a promising therapy for R/R follicular lymphoma
ASH 2024: Merck’s new ADC posts positive results in first-line DLBCL
ASH 2024: Galapagos presents positive results for a seven-day ‘vein-to-vein’ CAR T-cell therapy
ASH 2024: Arcellx publishes positive results for Anito-cel in multiple myeloma
